ElvySense Medical

The Gap in Sleep Diagnostics: A Billion-Person Challenge

Today’s diagnostic systems are struggling to keep pace with a global health crisis. While sleep apnea impacts over one billion people, the path to treatment remains broken.

*CE-mark coming in 2027

    • A Silent Crisis: The vast majority of cases remain undiagnosed due to prohibitive costs, long waiting lists, and high-friction testing.

    • The Diagnostic Barrier: Current clinical pathways are staff-intensive and slow, delaying critical treatment for patients at risk.

    • A Lack of Continuity: There is no simple, unobtrusive way to perform multi-night home testing or long-term follow-up monitoring.

  • As the healthcare landscape evolves— with the arrival of breakthrough drug therapies (e.g., AD109) and the move toward individualized therapy titration — the demand for effortless home monitoring has never been higher.

Clinical-Grade Sleep Apnea Detection With Minimal Contact to the Patient.

Sleep Apnea Detection. Reimagined. Our contactless diagnostic device is currently in clinical trials, offering medical-grade monitoring with minimal sleep disruption. We are advancing the CE-mark of the solution and we are targeting it for early 2027, we are now seeking for interested partners and users for pilot programs.

Receive more Information

ElvySense Medical next-generation multi-channel eBedSensor placed in the bed (coming in 2027)

ElvySense touchscreen control device (coming in 2027)

Nonin WristOx2 is a pulse oximeter

Proven Clinical Results and Ease of Use

Results from the clinical study:

  • The Device showed good clinical performance in detecting moderate-to-severe sleep apnea with 94.8% sensitivity and 88.2% specificity.

  • The Device-based OSA severity classification showed good performance with conventional AHI 5/15/30 thresholds

References

Benefits and future use cases:

  • Effortless Patient Experience: Self-setup in under two minutes with minimal body-worn sensors. Our "loaner case" system simplifies logistics, ensuring high device turnover and patient satisfaction.

  • A Unified Diagnostic Workflow: Seamlessly transition from a single-night screening to multi-night longitudinal studies. Perfect for both initial diagnosis and long-term treatment follow-ups.

  • Beyond the AHI: Access deep clinical insights. In addition to AHI, we track oxygen desaturation (ODI), breath rate, heart rate, and precise sleep-time estimates for a comprehensive health profile.

  • Operational Scalability: Designed for "staff-light" operations. With remote data review and automated reporting, you can clear waiting lists faster and significantly reduce the cost-per-patient.